Oxygenta Pharmaceutical Ltd — Insider Trade, 01-01-1970: Insider Trading / SAST

The company has announced a board meeting to approve the financial results for the quarter and half-year. This update signals the company’s ongoing transparency in its financial reporting, which is crucial for shareholders to track performance and make informed decisions. No additional changes or operational updates were disclosed.